Nicholas Lench, Angela Barrett, Sarah Fielding, Fiona McKay, Melissa Hill, Lucy Jenkins, Helen White and Lyn S. Chitty The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made Prenatal Diagnosis 33
What's already known about this topic?
- Non-invasive prenatal testing of cell-free fetal DNA in maternal plasma is widely used for aneuploidy detection, fetal RHD typing and fetal sex determination in pregnancies at high risk of sex-linked disorders.
What does this study add?
- We describe the current limited use of cell-free fetal DNA analysis for prenatal diagnosis of single-gene disorders and discuss the application of new technologies to aid implementation.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf